160,49 €*
Versandkostenfrei per Post / DHL
Aktuell nicht verfügbar
The book reviews novel aspects of functional genomics, epigenomics, transcriptomics, post-translational modifications, microbiome and immunometabolism in order to understand inflammatory signaling and responses, covering recent findings on the mechanisms underlying the regulation of inflammatory responses to pathogens, dysregulation of these responses in inflammatory disease, and the use of such mechanisms to boost or subdue the inflammatory response. Bridging the gaps in understanding between the fields of human and mouse immunology, it provides valuable insights into inflammatory-mediated disease and immune defense. Such innovative perspectives in both basic and clinical research promote the translation of knowledge to the clinic.
The book reviews novel aspects of functional genomics, epigenomics, transcriptomics, post-translational modifications, microbiome and immunometabolism in order to understand inflammatory signaling and responses, covering recent findings on the mechanisms underlying the regulation of inflammatory responses to pathogens, dysregulation of these responses in inflammatory disease, and the use of such mechanisms to boost or subdue the inflammatory response. Bridging the gaps in understanding between the fields of human and mouse immunology, it provides valuable insights into inflammatory-mediated disease and immune defense. Such innovative perspectives in both basic and clinical research promote the translation of knowledge to the clinic.
Dr. Dakang Xu is Professor at Shanghai Jiao Tong University and Institute of Ageing Research, Hangzhou Normal University, China. The main focus of his research team is to used a combination of genetically modified mouse models of disease, cell signalling, bioinformatics
analyses and clinical applications, to understand the mechanisms of regulation of epigenetic factors in inflammatory signalling. He has also studied how modulation of the activity ofthose key factors affects the inflammatory response and tumour progression, through the function of immune cell subsets and cytokines in cancer and inflammatory diseases. This work has led to 50 peer-reviewed publications in high impact journals, including Nature Immunology, Immunity, Nature Communications, PNAS and Cancer Research.Covers cutting-edge research in innate immunity
Reviews novel mechanisms in regulation of inflammation, such as microRNA and epigenetics
Discussing newly emerged innate lymphoid cells, which bridges innate and adaptive immunity
Written by experts in this field
Erscheinungsjahr: | 2017 |
---|---|
Fachbereich: | Therapie |
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Buch |
Reihe: | Advances in Experimental Medicine and Biology |
Inhalt: |
xii
244 S. 1 s/w Illustr. 18 farbige Illustr. 244 p. 19 illus. 18 illus. in color. |
ISBN-13: | 9789811059865 |
ISBN-10: | 9811059861 |
Sprache: | Englisch |
Herstellernummer: | 978-981-10-5986-5 |
Ausstattung / Beilage: | HC runder Rücken kaschiert |
Einband: | Gebunden |
Redaktion: | Xu, Dakang |
Herausgeber: | Dakang Xu |
Auflage: | 1st ed. 2017 |
Hersteller: |
Springer Singapore
Springer Nature Singapore Advances in Experimental Medicine and Biology |
Maße: | 241 x 160 x 19 mm |
Von/Mit: | Dakang Xu |
Erscheinungsdatum: | 02.10.2017 |
Gewicht: | 0,606 kg |
Dr. Dakang Xu is Professor at Shanghai Jiao Tong University and Institute of Ageing Research, Hangzhou Normal University, China. The main focus of his research team is to used a combination of genetically modified mouse models of disease, cell signalling, bioinformatics
analyses and clinical applications, to understand the mechanisms of regulation of epigenetic factors in inflammatory signalling. He has also studied how modulation of the activity ofthose key factors affects the inflammatory response and tumour progression, through the function of immune cell subsets and cytokines in cancer and inflammatory diseases. This work has led to 50 peer-reviewed publications in high impact journals, including Nature Immunology, Immunity, Nature Communications, PNAS and Cancer Research.Covers cutting-edge research in innate immunity
Reviews novel mechanisms in regulation of inflammation, such as microRNA and epigenetics
Discussing newly emerged innate lymphoid cells, which bridges innate and adaptive immunity
Written by experts in this field
Erscheinungsjahr: | 2017 |
---|---|
Fachbereich: | Therapie |
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Buch |
Reihe: | Advances in Experimental Medicine and Biology |
Inhalt: |
xii
244 S. 1 s/w Illustr. 18 farbige Illustr. 244 p. 19 illus. 18 illus. in color. |
ISBN-13: | 9789811059865 |
ISBN-10: | 9811059861 |
Sprache: | Englisch |
Herstellernummer: | 978-981-10-5986-5 |
Ausstattung / Beilage: | HC runder Rücken kaschiert |
Einband: | Gebunden |
Redaktion: | Xu, Dakang |
Herausgeber: | Dakang Xu |
Auflage: | 1st ed. 2017 |
Hersteller: |
Springer Singapore
Springer Nature Singapore Advances in Experimental Medicine and Biology |
Maße: | 241 x 160 x 19 mm |
Von/Mit: | Dakang Xu |
Erscheinungsdatum: | 02.10.2017 |
Gewicht: | 0,606 kg |